5-Fluorouracil derivatives
US4336381A · kind A · utility
105Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 1980 |
| Grant date | Jun 22, 1982 |
| Priority date | — |
| Expiry date | Nov 3, 2000 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Orally administrable 5-fluorouracil derivatives of the general formula: ##STR1## [wherein R.sup.1 is aryl or substituted aryl; R.sup.2 is acyclic or cyclic alkyl, adamantyl, aryl or substituted aryl; R.sup.3 and R.sup.4 are the same or different, each representing hydrogen atom or lower alkyl] effective against malignant tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.